Asthma Clinical Trial
Official title:
PCORI - The Imperial County CER Asthma Project
The immediate goal of the Imperial County CER Asthma project is to identify strategies to improve asthma control among children 0-17 years old and the asthma control behaviors of their families, their health care providers, and the communities in which they live. Our long-term goal is to improve the quality of life of children with asthma and potentially reduce families' economic and social burdens of uncontrolled asthma
Asthma is a prevalent chronic disease in rural and border communities along the U.S.-Mexico
border. Among 5-17 year olds, 20.2% have physician-diagnosed asthma compared to 16.2%
statewide. Risk factors for poor asthma control are well documented and include ambient air
quality, home environmental factors, and exposure to tobacco smoke. Although directionality
is not well established, obesity and poverty are related to asthma and are also prevalent in
the partner communities. These combined risk factors may explain the elevated rates of
emergency department use for asthma among children in Imperial County compared with the
state. Comprehensive approaches are needed that recognize and involve the various sectors
relevant to asthma control.
Objectives: The Imperial County's Asthma CER project is a family-clinic-community
intervention designed to improve asthma control. The objectives of this study are to
determine whether this combined approach (family clinic-community) is more effective at
promoting asthma control, quality of life and improved lung functioning than a
family-community intervention, a clinic-community intervention, or a community only
intervention. The ultimate goal is to identify feasible and effective methods for promoting
lifelong asthma control.
Methods: This is a 2x2 factorial (family and clinic) study nested within a community
intervention. Four hundred children 6-17 years old and a parent/legal guardian will be
recruited to participate in the study which includes random assignment to family home
visitations or no family home visits. Assignment in the second factor (clinic) will be
determined based on whether the child is a patient of the partner clinic (Clínicas de Salud
del Pueblo, Inc).
Patient Outcomes: Changes in children's asthma control, quality of life, and lung functioning
will be examined.
Partnerships to Facilitate Study: This study is a partnership between an academic/research
institute (San Diego State University and the Institute for Behavioral and Community Health)
with over 30 years of experience conducting rigorous public health research, a Federally
Qualified Health Center (Clínicas de Salud del Pueblo, Inc) with excellent reach and
credibility in the partner community, a community-based organization (Comité Cívico del
Valle) with extensive experience in promoting asthma control, and a division of the state
health department (California Breathing) responsible for asthma control efforts statewide.
Combined, they bring expertise in developing and implementing evidenced-based approaches for
real world settings to address urgent public health problems. Importantly, they have
successfully collaborated in the design, implementation and evaluation of over ten research
studies and/or projects within the last ten years.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|